Field
Example embodiments generally relate to isotopes and apparatuses and methods for production thereof in nuclear reactors.
Description of Related Art
Radioisotopes have a variety of medical and industrial applications stemming from their ability to emit discreet amounts and types of ionizing radiation and form useful daughter products. For example, radioisotopes are useful in cancer-related therapy, medical imaging and labeling technology, cancer and other disease diagnosis, and medical sterilization.
Radioisotopes having half-lives on the order of days are conventionally produced by bombarding stable parent isotopes in accelerators or low-power reactors with neutrons on-site at medical or industrial facilities or at nearby production facilities. These radioisotopes are quickly transported due to the relatively quick decay time and the exact amounts of radioisotopes needed in particular applications. Further, on-site production of radioisotopes generally requires cumbersome and expensive irradiation and extraction equipment, which may be cost-, space-, and/or safety-prohibitive at end-use facilities.
Because of difficulties with production and the lifespan of short-term radioisotopes, demand for such radioisotopes may far outweigh supply, particularly for those radioisotopes having significant medical and industrial applications in persistent demand areas, such as cancer treatment.
Example embodiments are directed to methods of producing desired isotopes in commercial nuclear reactors and associated irradiation targets. Example methods may utilize instrumentation tubes conventionally found in nuclear reactor vessels to expose irradiation targets to neutron flux found in the operating nuclear reactor. Desired isotopes may be produced in the irradiation targets due to the flux. These desired isotopes may then be relatively quickly and simply harvested by removing the irradiation targets from the instrumentation tube and reactor containment, without shutting down the reactor or requiring chemical extraction processes. The produced isotopes may then be immediately transported to end-use facilities.
Example embodiments include irradiation targets for use in nuclear reactors and instrumentation tubes thereof. Example embodiments may include one or more irradiation targets useable with example delivery systems that permit delivery of irradiation targets. Example embodiments may be sized, shaped, fabricated, and otherwise configured to successfully move through example delivery systems and conventional instrumentation tubes.
Example embodiments will become more apparent by describing, in detail, the attached drawings, wherein like elements are represented by like reference numerals, which are given by way of illustration only and thus do not limit the example embodiments herein.
Detailed illustrative embodiments of example embodiments are disclosed herein. However, specific structural and functional details disclosed herein are merely representative for purposes of describing example embodiments. The example embodiments may, however, be embodied in many alternate forms and should not be construed as limited to only example embodiments set forth herein.
It will be understood that, although the terms first, second, etc. may be used herein to describe various elements, these elements should not be limited by these terms. These terms are only used to distinguish one element from another. For example, a first element could be termed a second element, and, similarly, a second element could be termed a first element, without departing from the scope of example embodiments. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items.
It will be understood that when an element is referred to as being “connected,” “coupled,” “mated,” “attached,” or “fixed” to another element, it can be directly connected or coupled to the other element or intervening elements may be present. In contrast, when an element is referred to as being “directly connected” or “directly coupled” to another element, there are no intervening elements present. Other words used to describe the relationship between elements should be interpreted in a like fashion (e.g., “between” versus “directly between”, “adjacent” versus “directly adjacent”, etc.).
The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of example embodiments. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the language explicitly indicates otherwise. It will be further understood that the terms “comprises”, “comprising,”, “includes” and/or “including”, when used herein, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.
It should also be noted that in some alternative implementations, the functions/acts noted may occur out of the order noted in the figures. For example, two figures shown in succession may in fact be executed substantially and concurrently or may sometimes be executed in the reverse order, depending upon the functionality/acts involved.
The instrumentation tubes 50 may terminate below the reactor pressure vessel 10 in the drywell 20. Conventionally, instrumentation tubes 50 may permit neutron detectors, and other types of detectors, to be inserted therein through an opening at a lower end in the drywell 20. These detectors may extend up through instrumentation tubes 50 to monitor conditions in the core 15. Examples of conventional monitor types include wide range detectors (WRNM), source range monitors (SRM), intermediate range monitors (IRM), and/or Local Power Range Monitors (LPRM).
Although reactor pressure vessel 10 is illustrated with components commonly found in a commercial Boiling Water Reactor, example embodiments and methods may be useable with several different types of reactors having instrumentation tubes 50 or other access tubes that extend into the reactor. For example, Pressurized Water Reactors, Heavy-Water Reactors, Graphite-Moderated Reactors, etc. having a power rating from below 100 Megawatts-electric to several Gigawatts-electric and having instrumentation tubes 50 at several different positions from those shown in
Applicants have recognized that instrumentation tubes 50 may be useable to quickly and constantly generate desired isotopes on a large-scale basis without the need for chemical or isotopic separation and/or waiting for reactor shutdown of commercial reactors. Example methods may include inserting irradiation targets into instrumentation tubes 50 and exposing the irradiation targets to the core 15 while operating, thereby exposing the irradiation targets to the neutron flux commonly encountered in the operating core 15. The core flux may convert a substantial portion of the irradiation targets to a useful radioisotope, including short-term radioisotopes useable in medical applications. Irradiation targets may then be withdrawn from the instrumentation tubes 50, even during ongoing operation of the core 15, and removed for medical and/or industrial use.
Example Delivery Systems
Example delivery systems are discussed below in conjunction with example embodiment irradiation targets useable therewith, which are described in detail later. It is understood that example embodiment irradiation targets may be useable with other types of delivery systems than those described below.
An example cable 100 is illustrated in
As shown in
Referring to
An operator may configure first guide 400 and second guide 500 so that cable 100 may be advanced to a desired destination. For example, between loading/unloading area 2000 and instrumentation tube 50.
After configuring first and second guides 400 and 500, an operator may operate drive system 300 to advance cable 100 through tubing 200a, first guide 400, and second tubing 200b to place first end 114 of driving portion 110 of cable 100 into the loading/unloading area 2000. An operator may advance cable 100 by controlling a worm gear in drive system 300 that meshes with cable 100. The location of first end 114 of driving portion 110 of cable 100 may be tracked via markings 116 on cable 100. In the alternative, position of first end 114 of driving portion 110 of cable 100 may be known from information collected from a transducer that may be connected to drive system 300.
After the cable 100 has been positioned in the loading/unloading area 2000 example embodiment irradiation targets 122 may then be connected to cable 100 as described below with reference to example embodiment irradiation targets. An operator may operate drive system 300 to pull the cable from the loading/unloading area 2000 through tubing 200b and through first guide 400. The operator may then reconfigure first guide 400 to send cable 100 and example embodiment irradiation targets 122 to reactor pressure vessel 10. After the first guide 400 is reconfigured, the operator may advance cable 100 through third tubing 200c, second guide 500, fourth tubing 200d, and into a desired instrumentation tube 50. Location of first end 114 of the driving portion 110 of cable 100 may be tracked via markings 116 on cable 100. In the alternative, position of first end 114 of driving portion 110 of cable 100 may be known from information collected from a transducer that may be connected to a worm gear, for example.
After cable 100 bearing example embodiment irradiation targets 122 has been advanced to the appropriate location within instrumentation tube 50, the operator may stop cable 100 in the instrumentation tube 50. At this point, irradiation targets 122 may be irradiated for the proper time in the nuclear reactor. After irradiation, the operator may operate drive system 300 to pull cable 100 out of instrumentation tube 50, fourth tubing 200d, second guide 500, third tubing 200c, and/or first guide 400.
An operator may operate drive system 300 to advance cable 100 through first guide 400, and second tubing 200b to place first end 114 of driving portion of the cable 100 and example embodiment irradiation targets 122 into the loading/unloading area 2000. Example irradiation targets 122 may be removed from cable 100 and stored in a transfer cask or another desired location. An example transfer cask may be made of lead, tungsten, and/or depleted uranium in order to adequately shield the irradiated targets 122. Attachment and detachment of example embodiment irradiation targets 122 may be facilitated by the use of cameras which may be placed in the loading/unloading area 2000 to allow an operator to visually inspect the equipment during operation.
An alternate delivery system includes use of a conventional Transverse In-core Probe (TIP) system. A conventional TIP system 3000 is illustrated in
Because the TIP system includes a tubing system 3200a, 3200b, 3200c, and 3200d and/or a guide 3500 for guiding a cable 100 into an instrumentation tube 50, these systems may be used as an example delivery mechanism for example embodiment irradiation targets 122.
Cable 100 should be sized to function with existing tubing in example delivery systems and permit passage of example embodiment irradiation targets 122. For example, the inner diameter of tubing 3200a, 3200b, etc. may be approximately 0.3 inches. Accordingly, cable 100 may be sized so that dimensions transverse to the cable 100 do not exceed 0.3 inches.
Example Embodiment Irradiation Targets
Example delivery systems being described, example embodiment irradiation targets useable therewith are now described. It is understood that example targets devices may be configured/sized/shaped/etc. to interact with the example delivery systems discussed above, but example targets may also be used in other delivery systems and methods in order to be irradiated within a nuclear reactor.
Individual example irradiation targets 122a, 122b, and 122c are discussed below with reference to
Materials for irradiation targets 122a, 122b, and 122c and amount of exposure time in instrumentation tube 50 may be selected to determine the type and concentration of radioisotope produced. That is, because axial flux levels are known within an operating reactor, and because example embodiments may permit precise control of axial position of irradiation targets 122 used in example delivery apparatuses, the type and size of irradiation targets 122 and exposure time may be used to determine the resulting radioisotopes and their strength. It is known to one skilled in the art and from reference to conventional decay and cross-section charts what types of irradiation targets 122 will produce desired radioisotopes given exposure to a particular amount of neutron flux. Further, irradiation targets 122 may be chosen based on their neutron cross-section, so as to beneficially affect or not interfere with neutron flux at known axial positions in an operating commercial nuclear reactor core.
For example, it is known that Molybdenum-98 may be converted into Molybdenum-99 having a half-life of approximately 2.7 days when exposed to a particular amount of neutron flux. In turn, Molybdenum-99 decays to Technetium-99m having a half-life of approximately 6 hours. Technetium-99m has several specialized medical uses, including medical imaging and cancer diagnosis, and a short-term half-life. Using irradiation targets 122 fabricated from Molybdnenum-98 and exposed to a neutron flux in an operating reactor based on the size of irradiation target 122, Molybdenum-99 and/or Technetium-99m may be generated and harvested in example embodiment assemblies and methods by determining the mass of the irradiation target containing Mo-98, the axial position of the target in the operational nuclear core, the axial profile of the operational nuclear core, and the amount of time of exposure of the irradiation target. Further, because both Mo-98 and Tc-99m are solids, example targets may be fabricated entirely of Mo-98 or natural Molybdenum without need for additional containment, as may be required for liquid or gaseous targets and daughter products. Other solid target/daughter pairs may also take advantage of not needing additional containment and permitting maximum target/daughter mass, including, for example, Iridium/Platinum.
Example embodiment irradiation target 122a includes a hole 123a and a tapering portion 125a. Hole 123a passes through irradiation target 122a and has a position and diameter that permit wire 124 (
Tapering portion 125a is positioned at a front end of example embodiment irradiation target 122a with respect to target portion 120 (
Example embodiment irradiation target 122a may further include one or more rounded or chamfered edges 121a. Edges 121a may be rounded, chamfered, or otherwise made smooth at any point where an edge or protrusion may snag or rub against exterior tubing or an instrumentation tube 50, such as in tighter bends of tubing in example delivery devices. Example embodiment irradiation target 122a may have an overall length that further facilitates movement through bends of tubing in example delivery devices and/or instrumentation tubes 50. For example, target 122a may have a total length of approximately ½-1 inches in order to move through bends without becoming caught.
As shown in
Example embodiment irradiation target 122b may further include one or more rounded or chamfered edges 121b. Edges 121b may be rounded, chamfered, or otherwise made smooth at any point where an edge or protrusion may snag or rub against exterior tubing or an instrumentation tube 50, such as in tighter bends of tubing in example delivery devices. Example embodiment irradiation target 122b may have an overall length that further facilitates movement through bends of tubing in example delivery devices and/or instrumentation tubes. For example, target 122b may have a total length of approximately ½-1 inches in order to move through bends without becoming caught.
Example embodiment irradiation target 122b includes a hole 123b. Hole 123b passes through irradiation target 122b and has a position and diameter that permit wire 124 (
Example embodiment irradiation target 122c may further include one or more rounded or chamfered edges 121c. Edges 121c may be rounded, chamfered, or otherwise made smooth at any point to prevent or reduce the likelihood that an edge or protrusion may snag or rub against exterior tubing or an instrumentation tube 50, such as in tighter bends of tubing in example delivery devices. Example embodiment irradiation target 122c may have an overall length that further facilitates movement through bends of tubing in example delivery devices and/or instrumentation tubes 50. For example, target 122c may have a total length of approximately ½-1 inches in order to move through bends without becoming caught.
Example embodiment irradiation target 122c includes a hole 123b. Hole 123c may pass through target 122b and has a position and diameter that permit wire 124 (
As shown in
Example embodiment irradiation targets 122a/b/c are shown strung on wire 124 in order to preserve their position in target portion 120. It is understood that several other alternate joining mechanisms may be implemented to secure a position and/or order of example embodiment targets 122. For example, holes 123a/b/c shown in example embodiment irradiation targets 122a/b/c may be internally threaded by internal threads 126a or have other internal configurations that permit wire 124 to join to and/or be moved through irradiation targets 122a/b/c. Or for example, example targets 122a/b/c may be held together by an adhesive resin configured to maintain its adhesive properties when exposed to conditions in an instrumentation tube 50 of an operating nuclear reactor.
As shown in
In this way, one or more irradiation targets 122 may be placed in/joined to a delivery system, such as the ones illustrated in
Example embodiments thus being described, it will be appreciated by one skilled in the art that example embodiments may be varied through routine experimentation and without further inventive activity. Variations are not to be regarded as departure from the spirit and scope of the exemplary embodiments, and all such modifications as would be obvious to one skilled in the art are intended to be included within the scope of the following claims.
Number | Name | Date | Kind |
---|---|---|---|
3594275 | Ransohoff et al. | Jul 1971 | A |
3773615 | Blatter | Nov 1973 | A |
3879612 | Foster et al. | Apr 1975 | A |
3940318 | Arino et al. | Feb 1976 | A |
3998691 | Shikata et al. | Dec 1976 | A |
4196047 | Mitchem et al. | Apr 1980 | A |
4284472 | Pomares et al. | Aug 1981 | A |
4462956 | Boiron et al. | Jul 1984 | A |
4475948 | Cawley et al. | Oct 1984 | A |
4493813 | Loriot et al. | Jan 1985 | A |
4532102 | Cawley | Jul 1985 | A |
4597936 | Kaae | Jul 1986 | A |
4617985 | Triggs et al. | Oct 1986 | A |
4663111 | Kim et al. | May 1987 | A |
4729903 | McGovern et al. | Mar 1988 | A |
4782231 | Svoboda et al. | Nov 1988 | A |
4859431 | Ehrhardt | Aug 1989 | A |
5053186 | Vanderheyden et al. | Oct 1991 | A |
5145636 | Vanderhevden et al. | Sep 1992 | A |
5355394 | Van Geel et al. | Oct 1994 | A |
5400375 | Suzuki et al. | Mar 1995 | A |
5513226 | Baxter et al. | Apr 1996 | A |
5596611 | Ball | Jan 1997 | A |
5615238 | Wiencek et al. | Mar 1997 | A |
5633900 | Hassal | May 1997 | A |
5682409 | Caine | Oct 1997 | A |
5758254 | Kawamura et al. | May 1998 | A |
5867546 | Hassal | Feb 1999 | A |
5871708 | Park et al. | Feb 1999 | A |
5910971 | Ponomarev-Stepnoy et al. | Jun 1999 | A |
6056929 | Hassal | May 2000 | A |
6160862 | Wiencek et al. | Dec 2000 | A |
6192095 | Sekine et al. | Feb 2001 | B1 |
6233299 | Wakabayashi | May 2001 | B1 |
6456680 | Abalin et al. | Sep 2002 | B1 |
6678344 | O'Leary et al. | Jan 2004 | B2 |
6751280 | Mirzadeh et al. | Jun 2004 | B2 |
6804319 | Mirzadeh et al. | Oct 2004 | B1 |
6895064 | Ritter | May 2005 | B2 |
6896716 | Jones, Jr. | May 2005 | B1 |
7157061 | Meikrantz et al. | Jan 2007 | B2 |
7235216 | Kiselev et al. | Jun 2007 | B2 |
20020034275 | Abalin et al. | Mar 2002 | A1 |
20030012325 | Kernert et al. | Jan 2003 | A1 |
20030016775 | Jamriska, Sr. et al. | Jan 2003 | A1 |
20030103896 | Smith | Jun 2003 | A1 |
20030179844 | Filippone | Sep 2003 | A1 |
20030227991 | Kang et al. | Dec 2003 | A1 |
20040091421 | Aston et al. | May 2004 | A1 |
20040105520 | Carter | Jun 2004 | A1 |
20040196942 | Mirzadeh et al. | Oct 2004 | A1 |
20040196943 | Di Caprio | Oct 2004 | A1 |
20050105666 | Mirzadeh et al. | May 2005 | A1 |
20050118098 | Vincent et al. | Jun 2005 | A1 |
20050286675 | Kang et al. | Dec 2005 | A1 |
20060062342 | Gonzalez Lepera et al. | Mar 2006 | A1 |
20060126774 | Kim et al. | Jun 2006 | A1 |
20070133731 | Fawcett et al. | Jun 2007 | A1 |
20070133734 | Fawcett et al. | Jun 2007 | A1 |
20070297554 | Lavie et al. | Dec 2007 | A1 |
20080031811 | Ryu et al. | Feb 2008 | A1 |
20080076957 | Adelman | Mar 2008 | A1 |
Number | Date | Country |
---|---|---|
2653871 | Aug 2009 | CA |
36-007990 | Jun 1961 | JP |
50-58494 | May 1975 | JP |
59-120894 | Jul 1984 | JP |
436814 | May 2001 | TW |
200625344 | Jul 2006 | TW |
Entry |
---|
Swedish Office Action dated May 11, 2011 issued in connection with correspondg SE Application No. 1050864-6 together with unofficial English translation. |
Oct. 1, 2014 Taiwanese Office Action issued in corresponding TW Application No. 099127177 (translation). |
Sep. 2, 2014 Japanese Office Action issued in corresponding JP Application No. 2010-185695 (with translation). |
Number | Date | Country | |
---|---|---|---|
20110051872 A1 | Mar 2011 | US |